← FDA DRUG APPROVALS

FDA ANDA · ANDA080364

MEPERIDINE HYDROCHLORIDE

Sponsor: PARKE DAVIS

APPLICATION
ANDA080364
TYPE
ANDA
ORIGINAL APPROVAL
1976-05-19
LATEST ACTION
1976-05-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MEPERIDINE HYDROCHLORIDEDiscontinued
MEPERIDINE HYDROCHLORIDE 100MG/ML · INJECTABLE · INJECTION
MEPERIDINE HYDROCHLORIDEDiscontinued
MEPERIDINE HYDROCHLORIDE 50MG/ML · INJECTABLE · INJECTION
MEPERIDINE HYDROCHLORIDEDiscontinued
MEPERIDINE HYDROCHLORIDE 75MG/ML · INJECTABLE · INJECTION

Approval history

1976-05-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →